| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| ANL | ANL | Shares | USD | XNMS |
| TIDM | Instrument | Type | Currency | Venue |
|---|---|---|---|---|
| ANL | ANL | Shares | USD | XNMS |
Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company focused on developing cancer therapies. The company has a pipeline of drug candidates targeting precision RAS pathway therapies and next-generation PD-1/L1 pathway modulating immunotherapies. Adlai Nortye collaborates with various pharmaceutical companies to enhance drug discovery and development, aiming to provide treatment options for patients worldwide.
No recent RNS announcements for ANL across ANL.
No recent RNS announcements for ANL across ANL.